# Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

> **NCT00567580** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Radiation Therapy Oncology Group** · enrollment: 1792 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** PBRT
- **RADIATION:** PLNRT
- **DRUG:** AA
- **DRUG:** LHRH agonist

## Key facts

- **NCT ID:** NCT00567580
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2008-02
- **Primary completion:** 2018-07-12
- **Final completion:** —
- **Target enrollment:** 1792 (ACTUAL)
- **Last updated:** 2025-05-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567580, "Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00567580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*